- Press Release Distribution

Case report from Austria shows mpox breakthrough infection in man who had received both vaccine doses

A second case is currently under investigation


New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a ‘breakthrough’ mpox infection in January 2024. The authors believe breakthrough should be considered in fully vaccinated individuals engaging in high-risk behaviors. They also call for further research on the need for booster doses to protect against these breakthrough infections. The case report is by Dr Luigi Segagni-Lusignani, Public Health Authority, Vienna, Austria and colleagues. They add a second case, reported in the last few weeks (March 2024) is currently under investigation.

Following the sharp decline in notifications of new mpox infections after introducing the EMA-approved modified Vaccinia Ankara–Bavarian Nordic (MVA-BN) administration in late 2022 and early 2023, an upsurge in mpox cases occurred in the latter half of 2023 in European countries. Clusters were observed in individuals presumed immune through recent vaccination, but data on the durability of protective immunity after complete 2-dose vaccination are limited.

The authors here present a case of mpox infection in a 35-year-old, who had completed the two-dose course of intradermal third-generation Jynneos vaccine as pre-Exposure Prophylaxis (PrEP) on November 8, 2022, with a 28-day interval between the first and second dose. His medical history included well-controlled HIV infection since 2011 (CD4 count of > 700 cells/µL), hepatitis C infection in April 2017, SARS-CoV-2 infection in November 2020, and Campylobacter infections in August 2021 and January 2022.

In January 2024, five days after multiple sexual encounters during a Vienna event, the patient reported fever, chills, headache, discomfort urinating, diarrhoea with bleeding, and penile and anal itching. On day 3, a genital herpes infection was suspected, but no treatment was started. After two days, he presented to the dermatology clinic with worsening lymphadenopathy (swollen lymph nodes), where positive mpox virus PCR results were obtained. His Mpox Severity Score System (MPOX-SSS) was 10 (of a maximum score of 12).

No antiviral treatment was administered, no hospitalisation was required and the patient was home isolated. After 21 days, a control swab was still positive and the isolation had to be extended to day 25 from symptom onset, when finally all scabs fell off the lesions and PCR test on viral swab was negative.

The authors say: “This was Austria's first mpox breakthrough case. Despite no hospitalisation, the clinical course was not less severe than in unvaccinated patients, with longer disease duration and higher scores on the mpox severity scale. The 14-month interval between complete vaccination and infection suggests vaccine-induced immunity could be not durably protective. This case underscores the importance of clinical suspicion for mpox in high-risk groups, even if fully vaccinated with 2-doses. Breakthrough infections need to be explored further, as well as the possibility of vaccine boosters in vaccinated groups with epidemiological risky behaviours.”

They add: “The Austrian Vaccine Board updates its national mpox vaccine strategy annually based on new scientific evidence. Currently, there is no nationwide recommendation for booster shots after completing the currently recommend (Jynneos) vaccination regimen, even for high-risk groups. However, any potential changes to the vaccination strategy will depend on filling critical knowledge gaps in mpox immunity. These gaps include understanding the current level of immunity, the durability of immune responses, and the long-term vaccine effectiveness in high-risk groups.”



Scientists have a new tool in the race to improve the diagnosis and prognosis of sepsis

Researchers from Lund University in Sweden have identified distinct molecular signatures associated with the clinical signs of sepsis that could provide more accurate diagnosis and prognosis of sepsis, as well as help to target specific therapies at patients who would benefit most, according to new research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April). “A simple blood test when combined with a personalised risk model has the potential to save lives by providing more accurate sepsis diagnosis and determining who may go on to develop more severe clinical ...

UK Biobank study identifies ideal body weight for adults with type 2 diabetes to minimise risk of dying from cardiovascular disease

*This is an early press release from the European Congress on Obesity (ECO 2024) Venice 12-15 May. Please credit the Congress if using this material* New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimise their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease. The findings, based on health data from the UK Biobank, indicate that for adults aged 65 years or younger, maintaining a body mass index (BMI) within the normal range of 23–25 kg/m² was associated with the ...

Social media images of pediatric craniofacial patients – parents voice concerns

Waltham — March 29, 2024 — Parents voice strong concerns about social media sharing of images of children undergoing craniofacial surgery, reports a survey study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.  "Pediatric plastic surgeons must understand that consent and assent are necessary before posting patient images online," comments senior author Kenneth L. Fan, MD, of Georgetown ...

Researchers produce grafts that replicate the human ear

Researchers produce grafts that replicate the human ear
Researchers Produce Grafts that Replicate the Human Ear Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural. The study, published online in Acta Biomaterialia on March 16, offers the promise of grafts with well-defined anatomy and the correct biomechanical properties for those who are born with a congenital malformation or who lose an ear later in life. “Ear reconstruction requires multiple surgeries and an incredible amount of artistry ...

Hevolution Foundation issues $115 million call for applications for geroscience research opportunities

Hevolution Foundation issues $115 million call for applications for geroscience research opportunities
BOSTON, United States  — 29 March, 2024  — Based on the success of its 2023 HF-GRO program effort, Hevolution Foundation is issuing a call for applications for the 2024 iteration of the program. HF-GRO is an international effort to accelerate progress in healthy aging research. The major goal is to identify and support research that will further the Hevolution’s mission of extending healthy lifespan for the benefit of all humanity.  HF-GRO will ...

Rice study identifies protein responsible for gas vesicle clustering in bacteria

Rice study identifies protein responsible for gas vesicle clustering in bacteria
HOUSTON – (March 29, 2024) – Gas vesicles are hollow structures made of protein found in the cells of certain microorganisms, and researchers at Rice University believe they can be programmed for use in biomedical applications. “Inside cells, gas vesicles are packed in a beautiful honeycomb pattern. How this pattern is formed has never been thoroughly understood. We are presenting the first identification of a protein that can regulate this patterning, and we believe this will be a milestone in molecular microbiology,” said George Lu, assistant professor of bioengineering and a Cancer Prevention and Research Institute of Texas scholar. Lu and colleagues have published ...

AADOCR announces recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA)

Alexandria, VA – The American Association for Dental, Oral, and Craniofacial Research (AADOCR) has named the recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA). The recipients were recognized during the Opening Ceremonies of the 53rd Annual Meeting of the AADOCR, which was held in conjunction with the 102nd General Session of the International Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024 in New Orleans, LA. The winners are: CLINICAL RESEARCH & PUBLIC HEALTH CATEGORY 1st ...

Veterans help provide greater insight into Klinefelter and Jacobs syndromes

AURORA, Colo. (March 29,  2024) –Researchers at the University of Colorado Anschutz Medical Campus and collaborators across the country have conducted the largest and most diverse study of men with extra X or Y chromosomes in the US using a large dataset of military veterans. The results could lead to better diagnoses of these underrecognized conditions and earlier treatment of associated diseases. The study was published today in JAMA Network Open. “One in 400 males have an additional X or Y chromosome, however 86 percent of these individuals are not diagnosed,” said ...

Three renowned Argonne scientists accept joint appointments at the University of Houston

Three renowned Argonne scientists accept joint appointments at the University of Houston
HOUSTON, March 29, 2024 – Three top researchers with the U.S. Department of Energy’s Argonne National Laboratory have accepted joint appointments in various capacities at the University of Houston. These appointments are part of the memorandum of understanding (MoU) Argonne signed recently with the Greater Houston Partnership. The MoU creates greater collaboration across academia, industry, private investors and government to accelerate and scale decarbonization efforts in the region, with the goal of achieving a net-zero emissions economy by 2050, according to an Argonne press release. “This strategic collaboration leverages the combined strengths ...

High-resolution images reveal similarities in protein structures between Alzheimer’s disease and Down syndrome

INDIANAPOLIS – More than 90% of people with Down syndrome, the most common chromosomal disorder in humans and the most frequent genetic cause of intellectual disability, are diagnosed with Alzheimer’s disease by ages 55-60. A new study recently published in Nature Structural and Molecular Biology uses leading-edge cryo-electron microscopy imaging technology to determine whether differences exist between the protein structures in those with Alzheimer’s disease and those with both Alzheimer’s disease and Down syndrome. “Just like in Alzheimer’s disease, the neuropathological phenotype in those with ...


It takes two to TANGO: New strategy to tackle fibrosis and scarring

Researchers aim to analyze pangenomes using quantum computing

Ready and vigilant: immune cells on standby

Securing competitiveness of energy-intensive industries through relocation: The pulling power of renewables

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial

Social change may explain decline in genetic diversity of the Y chromosome at the end of the Neolithic period

Aston University research finds that social media can be used to increase fruit and vegetable intake in young people

A vaccine to fight antibiotic resistance

European Hormone Day 2024: Endocrine community unites to raise public awareness and push for policy action on hormone health

Good heart health in middle age may preserve brain function among Black women as they age

The negative effects of racism impact sleep in adolescents

Study uses wearable devices to examine 3- to 6-year-olds’ impulsivity, inattentiveness

Will future hurricanes compromise New England forests’ ability to store and sequester carbon?

Longest study to date assesses cognitive impairment over time in adults with essential tremor

Does a woman’s heart health affect cognition in midlife?

Unveiling the mysteries of cell division in embryos with timelapse photography

Survey finds loneliness epidemic runs deep among parents

Researchers develop high-energy-density aqueous battery based on halogen multi-electron transfer

Towards sustainable food systems: global initiatives and innovations

Coral identified as oldest bioluminescent organism, suggesting a new model of ancient ecology

SRI chosen by DARPA to develop next-generation computational design of metallic parts and intelligent testing of alloys

NJIT engineers muffle invading pathogens with a 'molecular mask'

Perinatal transmission of HIV can lead to cognitive deficits

The consumption of certain food additive emulsifiers could be associated with the risk of developing type 2 diabetes

New cancer research made possible as Surrey scientists study lipids cell by cell 

Bioluminescence first evolved in animals at least 540 million years ago

Squids’ birthday influences mating

Star bars show Universe’s early galaxies evolved much faster than previously thought

Critical minerals recovery from electronic waste

The move by Apple Memories to block potentially upsetting content illustrates Big Tech’s reach and limits, writes Chrys Vilvang

[] Case report from Austria shows mpox breakthrough infection in man who had received both vaccine doses
A second case is currently under investigation